1972
DOI: 10.1007/978-1-4684-3231-2_9
|View full text |Cite
|
Sign up to set email alerts
|

Platelet Factor 3 — Properties and Clinical Significance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1974
1974
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(1 citation statement)
references
References 17 publications
0
1
0
Order By: Relevance
“…During platelet secretion, several procoagulant and anti-coagulant factors as well as polyphosphates supporting factor XII activation are released [32,33]. In addition, strong platelet activation also foster coagulation via membrane changes rendering factors such as platelet factor 3 (PF3) available for interacting with plasmatic coagulation factors [34]. Platelet P-selectin upregulates tissue factor expression/release by monocytes [35] and is able to bind PSGL-1 on TF-positive extracellular vesicles [36] such that thrombin generation can therefore be accelerated [37] and coagulation can be fostered.…”
Section: Discussionmentioning
confidence: 99%
“…During platelet secretion, several procoagulant and anti-coagulant factors as well as polyphosphates supporting factor XII activation are released [32,33]. In addition, strong platelet activation also foster coagulation via membrane changes rendering factors such as platelet factor 3 (PF3) available for interacting with plasmatic coagulation factors [34]. Platelet P-selectin upregulates tissue factor expression/release by monocytes [35] and is able to bind PSGL-1 on TF-positive extracellular vesicles [36] such that thrombin generation can therefore be accelerated [37] and coagulation can be fostered.…”
Section: Discussionmentioning
confidence: 99%